Email updates

Keep up to date with the latest news and content from BMC Anesthesiology and BioMed Central.

Open Access Highly Accessed Research article

The effect of crystalloid versus medium molecular weight colloid solution on post-operative nausea and vomiting after ambulatory gynecological surgery - a prospective randomized trial

Ivan Hayes1, Raza Rathore1, Kingsley Enohumah1, Edgar Mocanu2, Deepak Kumar1 and Conan McCaul134*

Author Affiliations

1 Department of Anaesthesia, The Rotunda Hospital Dublin, Parnell Square, Dublin 1, Ireland

2 Royal College of Surgeons in Ireland, Dublin, Ireland

3 School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland

4 Mater Misericordiae University Hospital, Dublin, Ireland

For all author emails, please log on.

BMC Anesthesiology 2012, 12:15  doi:10.1186/1471-2253-12-15


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2253/12/15


Received:18 November 2011
Accepted:11 July 2012
Published:31 July 2012

© 2012 Hayes et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Intravenous fluid is recommended in international guidelines to improve patient post-operative symptoms, particularly nausea and vomiting. The optimum fluid regimen has not been established. This prospective, randomized, blinded study was designed to determine if administration of equivolumes of a colloid (hydroxyethyl starch 130/0.4) reduced post operative nausea and vomiting in healthy volunteers undergoing ambulatory gynecologic laparoscopy surgery compared to a crystalloid solution (Hartmann’s Solution).

Methods

120 patients were randomized to receive intravenous colloid (N = 60) or crystalloid (N = 60) intra-operatively. The volume of fluid administered was calculated at 1.5 ml.kg-1 per hour of fasting. Patients were interviewed to assess nausea, vomiting, anti-emetic use, dizziness, sore throat, headache and subjective general well being at 30 minutes and 2, 24 and 48 hours post operatively. Pulmonary function testing was performed on a subgroup.

Results

At 2 hours the proportion of patients experiencing nausea (38.2 % vs 17.9%, P = 0.03) and the mean nausea score were increased in the colloid compared to crystalloid group respectively (1.49 ± 0.3 vs 0.68 ± 0.2, P = 0.028). The incidence of vomiting and anti-emetic usage was low and did not differ between the groups. Sore throat, dizziness, headache and general well being were not different between the groups. A comparable reduction on post-operative FVC and FEV-1 and PEFR was observed in both groups.

Conclusions

Intra-operative administration of colloid increased the incidence of early postoperative nausea and has no advantage over crystalloid for symptom control after gynaecological laparoscopic surgery.

Keywords:
Fluid therapy; Colloid; Crystalloid solutions; Nausea; Vomiting

Background

The incidence of post operative nausea and vomiting (PONV) following ambulatory surgery is 40%–60% and ambulatory gynecological patients are at particularly high risk. PONV continues to occur despite pharmacological prophylaxis in high risk groups. [1-6] PONV has the potential to cause delays in meeting discharge criteria both from the recovery room to ward and from the day ward to home. [7-9] PONV causes patient discomfort and can result in unanticipated overnight hospital admission which leads to increased economic costs. PONV control is a strong patient priority and there is a strong association between PONV and patient dissatisfaction with their anesthesia care. [10-12] The routine use of anti-emetics remains controversial as their efficacy is limited in patients with low risk profiles. [13] In these circumstances, pharmacologic prophylaxis increases the risk of adverse drug effects for the patient in addition to increasing overall costs of care [13].

‘Rehydration’ is a recommended strategy to reduce PONV but have been subject to a relatively small number of studies in ambulatory anesthesia and there is no consensus as to which fluid or volume is optimal. [14-18] Studies suggest that intravenous crystalloid administration in healthy patients reduces the incidence of nausea, vomiting and antiemetic use after gynecological laparoscopy and other ambulatory procedures. [19-22] The anti-emetic efficacy of intravenous crystalloid appears to be dose related. Lower volumes do not have a significant effect and large volumes (30–40 ml/kg) are necessary to establish benefit. [19,23,24] Intravenous crystalloid has a short intravascular half life, its expected duration of action is short and solutions with longer durations of action e.g. colloid would be anticipated to have greater benefit. [25] We chose to study the effect of intravenous colloid solution in PONV and hypothesized that intravenous colloid would have a greater reduction on PONV than an equivalent volume of crystalloid solution.

Methods

Following approval by the Institutional Research Ethics committee (Rotunda Hospital, Dublin, Ireland), ASA I-II female patients, aged 18–45 years who were scheduled to undergo elective gynecological laparoscopy were invited to participate in the study. The study took place in the operating theatres, recovery room and day ward of the Rotunda Hospital, a tertiary level university teaching hospital. Exclusion criteria included age <18 or >45 years, cardio-respiratory disease, excessive intra-operative blood loss, BMI >30 and relevant drug allergy to medication used in the protocol. Informed written consent was obtained from all patients. Patients were randomized using a table of computer generated numbers each of which was linked to a sealed envelope that contained the allocation to one of two groups. The crystalloid group (CRL) received Compound Sodium Lactate at a volume of 1.5 ml.kg-1.hr-1 of fasting time administered as an intra-operative bolus. Compound Sodium Lactate (Baxter Health Care, Thetford, UK) contains sodium 131 mmol litre−1, potassium 5 mmol litre−1, calcium 2 mmol litre−1, chloride 111 mmol litre−1 and lactate 29 mmol litre−1. The colloid (CLD) group received 6% Hydroxy Ethyl Starch 130/0.4 in 0.9% saline (Voluven®; Fresenius Kabi, Bad Homburg, Germany) at a volume of 1.5 ml.kg-1.hr-1 of fasting time as an intra-operative bolus. To ensure blinding of both the patient and the investigator, all fluid administration was initiated after induction of anesthesia and completed prior to transfer to PACU. No further fluid was administered after this time. Neither the patient nor the investigator was aware of group assignment.

All patients received general anesthesia. Intravenous access was obtained after local anesthetic infiltration of the skin. Anesthesia was induced with fentanyl 1.5 mcg.kg-1, Propofol 2–3 mg.kg-1 and Atracurium 0.35 mg.kg-1 to facilitate airway control. The lungs were ventilated via a supraglottic airway (LMA Supreme™TM size 4) with tidal volume (Vt) 4–6 ml.kg-1, maximum airway pressure (P max) 30 cm H2O and a positive end expiratory pressure (PEEP) of 5 cm H2O. The respiratory rate was adjusted to maintain isocapnia. Anaesthesia was maintained with 1 MAC of Sevoflurane in a mixture of O2 and air to achieve a FiO2 of 0.5. Muscle relaxation was antagonized with neostigmine 2.5 mg and glycopyrrolate 0.5 mg at the end of surgery. Before discontinuation of anesthesia, each patient received rectal Diclofenac 100 mg and Paracetamol 1000 mg i.v. Prophylactic anti-emetics were not administered.

Postoperative care was standardized. In PACU, patients reporting pain were given 25 mcg of Fentanyl i.v. as required to achieve a pain score of 4 or less. On the ward Pethidine 50 mg intramuscularly or simple oral analgesics (Paracetamol/Codeine 500-1000 mg/8-16 mg were administered on a 3 and 6 hourly PRN basis as required respectively. Rescue anti-emetics were available in the form of ondansetron 4 mg i.v. in PACU and cyclizine 50 mg on the ward every 8 hours on a demand basis. In the event of failure of cyclizine, prochlorperazine 12.5 mg IM was available 8 hourly. Patients were prescribed oral Paracetamol/Codeine 500–1000 mg/8–16 mg every 6 hours and Diclofenac 50 mg every 8 hours to take at home if required.

The primary endpoint was the presence of nausea at 2 hours post-operatively. Nausea was assessed using a standard verbal rating scale (VRS 0 = no nausea, 10 = worst imaginable). [20] Secondary endpoints included vomiting, rescue antiemetic use, dizziness, sore throat and headache. Dry retching was considered to be vomiting for the purposes of the study. Symptoms were recorded as present or absent at each time point i.e. cumulative data were not reported. Anti-emetics were offered by PACU nursing staff to patients if they reported nausea when clinically assessed using a modified Aldrete score. [26] Pre and post-operative pulmonary function tests were performed in a subset of 30 patients following consultation with the institutional ethics committee after development of post-operative pulmonary edema in a study patient. Pulmonary function was assessed at the bedside using Viasys Microlab Spirometer (Viasys Healthcare, Warwick, United Kingdom) Patients were assessed by a single data collector (RR) at 30 mins, 2 hours, 24 hours and 48 hours postoperatively. The 24 and 48 hour assessments were carried out by telephone interview.

Statistics were performed using Sigma Stat, (Jandel Scientific). Categorical data were analyzed using the χ 2 test or the Fisher's exact test as appropriate. Continuous data were analyzed with the Student-t test or repeated measures analysis of variance as appropriate. Normally distributed data are presented as means and standard deviation and data that was not normally distributed is presented as medians and interquartile range. Categorical data is presented as proportions and percentages.

Sample size was calculated as follows: To detect a clinically significant difference of 25% reduction in mean nausea scores based on a baseline score of 40 mm, we calculated a sample size of 60 patients per group (a = 0.05, β = 0.2).

Results

There were no baseline differences between the groups in terms of age, weight, BMI, risk factors for PONV, fasting duration or anaesthetic technique (Table 1).

Table 1. Patient characteristics

At 2 hours the proportion of the patients experiencing nausea (38.2 vs 17.9%, P = 0.03) (Figure 2, Panel A) and the mean nausea score (1.49 ± 0.3 vs 0.68 ± 0.2, P = 0.028) (Figure 2, Panel B) and were increased in the colloid group compared to crystalloid respectively. There was no difference between the groups in these outcomes at any other time. The incidence of vomiting (Figure 1, Panel C) and anti-emetic usage (Table 2) was low and did not differ between the groups. Post-operative analgesic use was not different between the groups. (Table 2) Sore throat, dizziness, headache and general well being were not different between the groups post-operatively (Figure 3 Panels A-C). A comparable reduction on post-operative FVC and FEV-1 and PEFR was observed in both groups (Figure 4 Panels A-C).

thumbnailFigure 1. Panel A: Data are percentage. *Indicates P < 0.05. Panel B: Verbal Analogue Score of Nausea. (0 = No Nausea 10 = Worst Possible) Data are non parametric and presented as mean and standard error of the mean. * Indicates P = 0.028. Panel C: Data are percentage.

Table 2. Post-operative medication

thumbnailFigure 2. Consort flow diagram.

thumbnailFigure 3. All data are percentage.

thumbnailFigure 4. Panel A: Data are non parametric and presented as mean and standard error of the mean. * Indicates P < 0.05 for post operative crystalloid and colloid vs. baseline (P=0.013, 0.016 respectively). Panel B: Data are non parametric and presented as mean and standard error of the mean. * Indicates P < 0.05 for post operative crystalloid and colloid vs. baseline (P=0.025, 0.012 respectively). Panel C: Data are non parametric and presented as mean and standard error of the mean. * Indicates P < 0.05 for post operative crystalloid and colloid vs. baseline (P=0.001, 0.004 respectively).

One patient was withdrawn from the colloid group after developing high airway pressures in the operating room. In PACU a chest x-ray showed pulmonary edema which was treated with diuretics and oxygen. She was well at follow up.

Discussion

Multiple previous prospective randomized clinical trials have demonstrated a reduction in post-operative nausea and vomiting associated with intravenous crystalloid administration which is dose related. [19-22,24,27,28] Intravenous fluid administration has also been shown to improve multiple other common post-operative symptoms and to shorten time to achieving discharge criteria. [21,23] Recent consensus guidelines by the ASA and ASPAN recommend peri-operative rehydration to reduce baseline risk of PONV but no specific fluid formulation or volume or rate of administration have been advocated. [16,17] The present study aimed to determine whether a colloidal solution may have any advantage over crystalloid in magnitude or duration of effect on PONV. We did not confirm any such benefit and in fact demonstrated an increase in early nausea in patients receiving the colloid solution. The observed nausea was mild and did not affect general well being. Secondary outcomes – the incidence of headache, sore throat and dizziness were not improved by colloid administration.

There have been a small number of related studies in diverse patient populations to date and none in ambulatory care specifically. The results of these studies have been conflicting. Haentjens, in a prospective randomised trial investigated the effect of hydroxyethyl starch 130/0.4 or saline in a mixed surgical population undergoing non-ambulatory surgery and showed no difference between the groups in nausea and vomiting. [29] The volumes of experimental fluids were similar to those used in our study but were administered over a 24 hour period whereas in our study they were administered intra-operatively – a considerably shorter time period of greater relevance to the ambulatory surgical population. Moretti investigated the effect of 6% hetastarch in either balanced salt (HS-NS) or lactated Ringer’s solution (HS-BS) with lactated Ringer’s in an older population undergoing major intracavity surgery. [30] Fluid administration was algorithmically determined and PONV was more common in patients receiving Ringer’s lactate and clinical evidence suggested that significant interstitial oedema developed in this group. The authors speculated that the reduction in PONV in the colloid group was due to less bowel edema. It is perhaps unsurprising that tissue edema occurred in the crystalloid group as these patients received a mean volume of 5946 ml compared to 1301 ml and 1448 ml in the HS-NS and HS-BS groups respectively. In a study of healthy non-anaesthetised volunteers, subjects receiving 50 ml/kg of sodium chloride reported abdominal discomfort more frequently than those who received an equivalent volume of lactated Ringer’s solution, indicating a possible difference in the tendency to cause bowel edema between these solutions. [31] Wilkes studied 6% hetastarch in either Hartmann’s solution or 0.9% Sodium Chloride in elderly patients undergoing open surgery and showed improved gastric perfusion and a trend toward less vomiting in the former group, suggesting that the electrolyte composition of the colloidal solution has some influence on its emetogenic potential. [32] In a study of female patients undergoing elective laparoscopic cholecystectomy, Chaudhary did not demonstrate any differences on PONV between groups receiving 12 ml.kg-1 of Ringers lactate or 12 ml.kg-1 4.5% Hydroxyethyl starch prior to induction of anaesthesia. This study was notable for an extremely high incidence of PONV. [33] The colloid intervention group also received a subsequent infusion of Ringers lactate and final fluid volumes were not reported. In a study of patients undergoing cholecystectomy, Turkistani administered 10 ml.kg-1 of one of three colloidal study solutions of low, medium and high molecular weight respectively. [34] The study was underpowered to detect a difference between colloid groups but showed a distinct trend towards greater PONV with increasing molecular weight.

In the studies which have been carried out to date on the effects of intravenous fluids on PONV after gynaecological laparoscopy, the specific mechanism of action of fluid has not been determined. Intravenous fluids have not been found to be beneficial in thyroidectomy and therapeutic abortion suggesting that the effect may be specific to laparoscopic surgery. [35,36] Speculative mechanisms of PONV after laparoscopy include a reduction in gut mucosal blood flow that is known to occur during pneumoperitoneum and anaesthesia. [37] Mesenteric hypoperfusion in turn may lead to release of 5-hydroxytryptamine which is a potent trigger of nausea and vomiting. High volume intravenous fluids have also been shown to reduce post-operative pain and could potentially reduce opioid consumption, both of which can be emetogenic. We chose to study hydroxyethyl starch 130/0.4 which is a medium molecular weight starch in a balanced electrolyte solution designed to minimize tissue accumulation and coagulation dysfunction while retaining the hemodynamic efficacy of conventional starches. [38] We anticipated that the colloidal study solution would have a more marked and sustained effect than crystalloid on restoration of intravascular volume and consequently reduce intestinal mucosal ischemia and subsequent PONV. [39] The findings of the study were opposite to that expected and a greater proportion of the patients who received colloid were nauseated. We speculate that this observation is explicable by a relative increase in blood viscosity that has been previously reported with hydroxyethyl starches that may paradoxically impair microcirculatory perfusion. The observation that highest incidence of nausea occurred at 2 hours post-operatively in both groups and occurred more commonly in patients who had received intravenous fentanyl in PACU, suggests that the mechanism of nausea in this study population was at least in part opioid induced, which is not known to be ameliorated by intravenous fluid administration.

Our study has a number of limitations. First, there was no untreated control group and a single dose of colloid was evaluated, therefore beneficial effects of the solution at different doses cannot be excluded. Second, blinding is incomplete as the anaesthetist who administered the fluids was not blinded. Third, the study was conducted in patients without cardiorespiratory disease and use of such volumes of rapidly administered intravenous fluids cannot be recommended to all patients. Fourth, the study was underpowered to demonstrate statistical differences for secondary outcomes, particularly pulmonary function which showed clear trends towards greater impairment in the colloid group. Fifth, following discharge from PACU oral intake was not restricted or measured. Last, prophylactic anti-emetics were not administered, limiting the ability of clinicians to extrapolate of our findings to patients who receive such interventions.

Conclusion

In conclusion, we were unable to demonstrate a benefit of colloid over crystalloid in PONV after ambulatory gynecologic surgery and cannot recommend it at the investigated dose for this purpose.

Competing interests

None of the authors have any financial or non-financial competing interests.

Authors’ contributions

IH designed the study, analyzed the data and drafted the manuscript. RR collected data and was involved in drafting the manuscript. KE collected data, was involved in its analysis and manuscript drafting. EM was involved in drafting the manuscript. DK collected data. CMC designed the study, co-ordinated it, analyzed the data and drafted the manuscript. All authors saw and approved the final manuscript.

Funding

Internal Department only.

Acknowledgements

The authors would like to acknowledge the contribution of Dr Roisin Ni Mhuircheartaigh to the statistical analysis of this study.

References

  1. Fujii Y: The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy.

    Curr Pharm Des 2005, 11:3173-3183. PubMed Abstract | Publisher Full Text OpenURL

  2. White PF, O’Hara JF, Roberson CR, Wender RH, Candiotti KA: The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients.

    Anesth Analg 2008, 107:452-458. PubMed Abstract | Publisher Full Text OpenURL

  3. Wender RH: Do current antiemetic practices result in positive patient outcomes? Results of a new study.

    Am J Health Syst Pharm 2009, 66:S3-S10. PubMed Abstract | Publisher Full Text OpenURL

  4. Lichtor JL, Glass PS: We’re tired of waiting.

    Anesth Analg 2008, 107:353-355. PubMed Abstract | Publisher Full Text OpenURL

  5. Pan PH, Lee SC, Harris LC: Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.

    Anesth Analg 2008, 107:429-438. PubMed Abstract | Publisher Full Text OpenURL

  6. Fujii Y, Toyooka H, Tanaka H: Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.

    Br J Anaesth 1998, 80:248-249. PubMed Abstract | Publisher Full Text OpenURL

  7. Edler AA, Mariano ER, Golianu B, Kuan C, Pentcheva K: An analysis of factors influencing postanesthesia recovery after pediatric ambulatory tonsillectomy and adenoidectomy.

    Anesth Analg 2007, 104:784-789. PubMed Abstract | Publisher Full Text OpenURL

  8. Gundzik K: Nausea and vomiting in the ambulatory surgical setting.

    Orthop Nurs 2008, 27:182-188. PubMed Abstract | Publisher Full Text OpenURL

  9. Patel RI, Hannallah RS: Anesthetic complications following pediatric ambulatory surgery: a 3-yr study.

    Anesthesiology 1988, 69:1009-1012. PubMed Abstract | Publisher Full Text OpenURL

  10. Macario A, Weinger M, Carney S, Kim A: Which clinical anesthesia outcomes are important to avoid? The perspective of patients.

    Anesth Analg 1999, 89:652-658. PubMed Abstract | Publisher Full Text OpenURL

  11. Macario A, Weinger M, Truong P, Lee M: Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists.

    Anesth Analg 1999, 88:1085-1091. PubMed Abstract | Publisher Full Text OpenURL

  12. Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM: Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients.

    Br J Anaesth 2000, 84:6-10. PubMed Abstract | Publisher Full Text OpenURL

  13. Alkaissi A, Gunnarsson H, Johnsson V, Evertsson K, Ofenbartl L, Kalman S: Disturbing post-operative symptoms are not reduced by prophylactic antiemetic treatment in patients at high risk of post-operative nausea and vomiting.

    Acta Anaesthesiol Scand 2004, 48:761-771. PubMed Abstract | Publisher Full Text OpenURL

  14. Rusch D, Eberhart LH, Wallenborn J, Kranke P: Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

    Dtsch Arztebl Int 107:733-741. OpenURL

  15. Kovac AL: Prevention and treatment of postoperative nausea and vomiting.

    Drugs 2000, 59:213-243. PubMed Abstract | Publisher Full Text OpenURL

  16. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, Hooper VD, Kovac AL, Kranke P, Myles P: Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting.

    Anesth Analg 2007, 105:1615-1628. PubMed Abstract | Publisher Full Text OpenURL

  17. ASPAN'S evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV

    J Perianesth Nurs 2006, 21:230-250. PubMed Abstract | Publisher Full Text OpenURL

  18. Doherty M, Buggy DJ: Intraoperative fluids: how much is too much?

    Br J Anaesth 2012, 109:69-79. PubMed Abstract | Publisher Full Text OpenURL

  19. Magner JJ, McCaul C, Carton E, Gardiner J, Buggy D: Effect of intraoperative intravenous crystalloid infusion on postoperative nausea and vomiting after gynaecological laparoscopy: comparison of 30 and 10 ml kg(−1).

    Br J Anaesth 2004, 93:381-385. PubMed Abstract | Publisher Full Text OpenURL

  20. Maharaj CH, Kallam SR, Malik A, Hassett P, Grady D, Laffey JG: Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients.

    Anesth Analg 2005, 100:675-682. PubMed Abstract | Publisher Full Text OpenURL

  21. Yogendran S, Asokumar B, Cheng DC, Chung F: A prospective randomized double-blinded study of the effect of intravenous fluid therapy on adverse outcomes on outpatient surgery.

    Anesth Analg 1995, 80:682-686. PubMed Abstract | Publisher Full Text OpenURL

  22. Ali SZ, Taguchi A, Holtmann B, Kurz A: Effect of supplemental pre-operative fluid on postoperative nausea and vomiting.

    Anaesthesia 2003, 58:780-784. PubMed Abstract | Publisher Full Text OpenURL

  23. Holte K, Klarskov B, Christensen DS, Lund C, Nielsen KG, Bie P, Kehlet H: Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy: a randomized, double-blind study.

    Ann Surg 2004, 240:892-899. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  24. McCaul C, Moran C, O'Cronin D, Naughton F, Geary M, Carton E, Gardiner J: Intravenous fluid loading with or without supplementary dextrose does not prevent nausea, vomiting and pain after laparoscopy.

    Can J Anaesth 2003, 50:440-444. PubMed Abstract | Publisher Full Text OpenURL

  25. Hiltebrand LB, Kimberger O, Arnberger M, Brandt S, Kurz A, Sigurdsson GH: Crystalloids versus colloids for goal-directed fluid therapy in major surgery.

    Crit Care 2009, 13:R40. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  26. Aldrete JA: Modificationsto the postanesthesia score for use in ambulatory surgery.

    J Perianesth Nurs 1998, 13:148-155. PubMed Abstract | Publisher Full Text OpenURL

  27. Keane PW, Murray PF: Intravenous fluids in minor surgery. Their effect on recovery from anaesthesia.

    Anaesthesia 1986, 41:635-637. PubMed Abstract | Publisher Full Text OpenURL

  28. Cook R, Anderson S, Riseborough M, Blogg CE: Intravenous fluid load and recovery. A double-blind comparison in gynaecological patients who had day-case laparoscopy.

    Anaesthesia 1990, 45:826-830. PubMed Abstract | Publisher Full Text OpenURL

  29. Haentjens LL, Ghoundiwal D, Touhiri K, Renard M, Engelman E, Anaf V, Simon P, Barvais L, Ickx BE: Does infusion of colloid influence the occurrence of postoperative nausea and vomiting after elective surgery in women?

    Anesth Analg 2009, 108:1788-1793. PubMed Abstract | Publisher Full Text OpenURL

  30. Moretti EW, Robertson KM, El-Moalem H, Gan TJ: Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration.

    Anesth Analg 2003, 96:611-617.

    table of contents

    PubMed Abstract | Publisher Full Text OpenURL

  31. Williams EL, Hildebrand KL, McCormick SA, Medel MJ: The Effect of Intravenous Lactated Ringer's Solution Versus 0.9% Sodium Chloride on Serum Osmolality in Human Volunteers.

    Anesth Analg 1999, 88:999-1003. PubMed Abstract | Publisher Full Text OpenURL

  32. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG: The Effects of Balanced Versus Saline-Based Hetastarch and Crystalloid Solutions on Acid–base and Electrolyte Status and Gastric Mucosal Perfusion in Elderly Surgical Patients.

    Anesth Analg 2001, 93:811-816. PubMed Abstract | Publisher Full Text OpenURL

  33. Chaudhary S, Sethi AK, Motiani P, Adatia C: Pre-operative intravenous fluid therapy with crystalloids or colloids on post-operative nausea & vomiting.

    Indian J Med Res 2008, 127:577-581. PubMed Abstract | Publisher Full Text OpenURL

  34. Turkistani A, Abdullah K, Manaa E, Delvi B, Khairy G, Abdulghani B, Khalil N, Damas F, El-Dawlatly A: Effect of fluid preloading on postoperative nausea and vomiting following laparoscopic cholecystectomy.

    Saudi J Anaesth 2009, 3:48-52. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  35. Ooi LG, Goldhill DR, Griffiths A, Smith C: IV fluids and minor gynaecological surgery: effect on recovery from anaesthesia.

    Br J Anaesth 1992, 68:576-579. PubMed Abstract | Publisher Full Text OpenURL

  36. Dagher CF, Abboud B, Richa F, Abouzeid H, El-Khoury C, Doumit C, Yaghi C, Yazbeck P: Effect of intravenous crystalloid infusion on postoperative nausea and vomiting after thyroidectomy: a prospective, randomized, controlled study.

    Eur J Anaesthesiol 2009, 26:188-191. PubMed Abstract | Publisher Full Text OpenURL

  37. Caldwell CB, Ricotta JJ: Changes in visceral blood flow with elevated intraabdominal pressure.

    J Surg Res 1987, 43:14-20. PubMed Abstract | Publisher Full Text OpenURL

  38. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H: Hydroxyethyl starches: different products–different effects.

    Anesthesiology 2009, 111:187-202. PubMed Abstract | Publisher Full Text OpenURL

  39. Grocott MP, Mythen MG, Gan TJ: Perioperative fluid management and clinical outcomes in adults.

    Anesth Analg 2005, 100:1093-1106. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2253/12/15/prepub